Literature DB >> 19864198

Key process indicators of mortality in the implementation of protocol-driven therapy for severe sepsis.

Jiun-Long Wang1, Chun-Shih Chin, Ming-Chen Chang, Chi-Yuan Yi, Sou-Jen Shih, Jeng-Yuan Hsu, Chieh-Liang Wu.   

Abstract

BACKGROUND/
PURPOSE: Severe sepsis and septic shock are life-threatening disorders. Integrating treatments into a bundle strategy has been proposed to facilitate timely resuscitation, but is difficult to implement. We implemented protocol-driven therapy for severe sepsis, and analyzed retrospectively the key process indicators of mortality in managing sepsis.
METHODS: Continuous quality improvement was begun to implement a tailored protocol-driven therapy for sepsis in a 24-bed respiratory intensive care unit (RICU) of Taichung Veterans General Hospital from January 2007 to February 2008. Patients, who were admitted to the RICU directly, or within 24 hours, were enrolled if they met the criteria for severe sepsis and septic shock. Disease severity [Acute Physiology and Chronic Health Evaluation (APACHE) II and lactate level], causes of sepsis, comorbidity and site of sepsis onset were recorded. Process-of-care indicators included resuscitation time (Tr-s), RICU bed availability (Ti-s) and the ratio of completing the elements of the protocol at 1, 2, 4 and 6 hours. The structure and process-of-care indicators reflated to mortality at 7 days after RICU admission and at RICU discharge were identified retrospectively.
RESULTS: Eighty-six patients (mean age, 71 +/- 14 years, 72 men, 14 women, APACHE II, 25.0 +/- 7.0) were enrolled. APACHE II scores and lactate levels were higher for mortality than survival at 7 days after RICU admission (p < 0.01). For the process-of-care indicators, Ti-s (562.2 +/- 483.3 vs.1017.3 +/- 557.8 minutes, p = 0.03) and Tr-s (60.7 +/- 207.8 vs. 248.5 +/- 453.1 minutes, p = 0.07) were shorter for survival than mortality at 7 days after RICU admission. The logistic regression study showed that Tr-s was an important indicator. The ratio of completing the elements of protocols at 1, 2, 4 and 6 hours ranged from 70% to 90% and was not related to mortality.
CONCLUSION: Protocol-driven therapy for sepsis was put into clinical practice. Early resuscitation and ICU bed availability were key process indicators in managing sepsis, to reduce mortality.

Entities:  

Mesh:

Year:  2009        PMID: 19864198     DOI: 10.1016/S0929-6646(09)60405-8

Source DB:  PubMed          Journal:  J Formos Med Assoc        ISSN: 0929-6646            Impact factor:   3.282


  5 in total

1.  Emergency Physician Compliance with Quality Indicators of Septic Shock and Severe Sepsis in Eastern Taiwanese Community Hospital.

Authors:  Chih-Chang Liu; Wan-Hua Annie Hsieh; Pei-Fang Lai; Sheng-Chuan Hu; Hui-Yi Huang; Zen Lang Bih
Journal:  J Acute Med       Date:  2017-12-01

Review 2.  The effect of diabetes on mortality in critically ill patients: a systematic review and meta-analysis.

Authors:  Sarah E Siegelaar; Maartje Hickmann; Joost B L Hoekstra; Frits Holleman; J Hans DeVries
Journal:  Crit Care       Date:  2011-09-13       Impact factor: 9.097

3.  Clinical outcomes and mortality before and after implementation of a pediatric sepsis protocol in a limited resource setting: A retrospective cohort study in Bangladesh.

Authors:  Teresa Bleakly Kortz; David M Axelrod; Mohammod J Chisti; Saraswati Kache
Journal:  PLoS One       Date:  2017-07-28       Impact factor: 3.240

4.  Late recognition and illness severity are determinants of early death in severe septic patients.

Authors:  Flavia R Machado; Reinaldo Salomão; Otelo Rigato; Elaine M Ferreira; Guilherme Schettino; Tatiane Mohovic; Carla Silva; Isac Castro; Eliezer Silva
Journal:  Clinics (Sao Paulo)       Date:  2013-05       Impact factor: 2.365

5.  Differences in sepsis treatment and outcomes between public and private hospitals in Brazil: a multicenter observational study.

Authors:  Katia Aparecida Pessoa Conde; Eliezer Silva; Carla Oliveira Silva; Elaine Ferreira; Flavio Geraldo Rezende Freitas; Isac Castro; Alvaro Rea-Neto; Cintia Magalhaes Carvalho Grion; Anselmo Dornas Moura; Suzana Margareth Lobo; Luciano Cesar Pontes Azevedo; Flavia Ribeiro Machado
Journal:  PLoS One       Date:  2013-06-06       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.